Acter (5536) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
10 Jun, 2026Executive summary
Achieved record-high consolidated revenue of NT$8.56 billion in Q1 2025, up 56% year-over-year, with EPS of NT$5.18 and a backlog exceeding NT$46 billion, supporting future operations.
Net income attributable to owners was NT$642.9 million, a 50% increase year-over-year, with strong growth in Taiwan and other Asian markets.
Maintains a strong presence in Taiwan, China, and Southeast Asia, with diversified industry exposure, especially in semiconductors and cleanroom electromechanical services.
Gross margin was 18% in Q1 2025, down from 21% in Q1 2024, reflecting higher project volumes and cost management.
Financial highlights
Operating revenue rose to NT$8.56 billion in Q1 2025 from NT$5.48 billion in Q1 2024, a 56% increase.
Operating income for Q1 2025 was NT$1,023.7 million, up 47% year-over-year.
Profit after tax reached NT$876 million, up 49% YoY; ROE improved to 5.37% for the quarter.
Cash and cash equivalents at end of Q1 2025 were NT$9.61 billion, despite negative operating cash flow.
Total assets increased to NT$34,858 million, with total liabilities at NT$18,955 million and short-term borrowings of NT$986 million.
Outlook and guidance
High backlog of over NT$46 billion ensures robust future revenue streams.
Cleanroom and semiconductor markets expected to grow, with global cleanroom technology market CAGR projected at 5.97% through 2032.
Focus on leveraging AI, regionalized supply chains, and net-zero carbon opportunities for long-term growth.
The group is evaluating the impact of new IFRS standards, including IFRS 18, effective January 2027.
Anticipates potential reclassification of ESG-linked bonds under upcoming IFRS amendments.
Latest events from Acter
- Q1 2024 delivered strong margins, record backlog, robust cash, and a qualified audit review.5536
Q1 202410 Jun 2026 - Record-high revenue and EPS, strong backlog, and improved gross margin at 22%.5536
Q3 202410 Jun 2026 - Record 2024H1 EPS, strong backlog, and top ESG/ROE metrics, with a qualified auditor review.5536
Q2 202410 Jun 2026 - Record revenue, high backlog, and margin gains drive a strong outlook for 2024.5536
Q4 202410 Jun 2026 - Record revenue and EPS in 2025H1, with strong backlog and some credit risk concentration.5536
Q2 202510 Jun 2026 - Record revenue and EPS in 2025 Q1–Q3, with strong backlog and ongoing legal and credit risks.5536
Q3 202510 Jun 2026 - Record revenue, high backlog, and strong EPS growth driven by semiconductor and cleanroom projects.5536
Q1 202610 Jun 2026 - Record revenue, strong backlog, and high ROE drive growth and sustained high dividends.5536
Q4 202510 Jun 2026